Equibles does not estimate personal net worth.
Matthew Korenberg was last confirmed as CFO at Ligand Pharmaceuticals Inc (LGND) in a filing dated April 22, 2022. Earlier roles on record: COO at Ligand Pharmaceuticals Inc (LGND) until October 15, 2024. Ligand Pharmaceuticals Inc reported in an 8-K filed November 4, 2022 that Matthew Korenberg was appointed President and Chief Operating Officer, effective November 1, 2022. The proxy statement of Ligand Pharmaceuticals Inc reports total compensation of $13,165,669 for Matthew Korenberg in fiscal 2024, including a base salary of $385,545. Disclosed compensation is on record for 8 fiscal years. Matthew Korenberg has spoken on 2 earnings calls across 1 company, most recently for Ligand Pharmaceuticals Inc on November 7, 2022. The companies whose calls Matthew Korenberg spoke on are classified in the Healthcare sector.
“Matthew Korenberg, 47, who until then served as Ligand's Executive Vice President, Finance and Chief Financial Officer was appointed as Ligand's President and Chief Operating Officer.”
“I'll echo John's earlier comments and say that I'm also very excited to have the OmniAb spin-off complete, and I look forward to tracking our former colleagues’ success as an independent public company.”
“The first quarter of 2021 provided a strong start to the year for Ligand. Total revenue for the quarter was $55.2 million, up from $33.2 million a year ago. With respect to royalties, royalty revenue increased to $7.1 million from $6.6 million a year ago.”
Start not stated–2022-04-22
Last confirmed by a filing; no departure on record
Start not stated–2024-10-15
Biotechnology · Healthcare
CFO, COO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Ligand Pharmaceuticals Inc (LGND) | Former President and Chief Operating Officer | $385,545 | $13,165,669 |
| 2023 | Ligand Pharmaceuticals Inc (LGND) | Former President and Chief Operating Officer | $549,912 | $3,587,288 |
| 2022 | Ligand Pharmaceuticals Inc (LGND) | Former President and Chief Operating Officer | $519,858 | $6,542,545 |
| 2021 | Ligand Pharmaceuticals Inc (LGND) | President and Chief Operating Officer | $497,297 | $6,725,479 |
| 2020 | Ligand Pharmaceuticals Inc (LGND) | President and Chief Operating Officer | $482,833 | $3,111,136 |
| 2019 | Ligand Pharmaceuticals Inc (LGND) | Executive Vice President, Finance and Chief Financial Officer | $466,667 | $3,571,203 |
| 2018 | Ligand Pharmaceuticals Inc (LGND) | Executive Vice President, Finance and Chief Financial Officer | $428,438 | $2,668,630 |
| 2017 | Ligand Pharmaceuticals Inc (LGND) | Executive Vice President, Finance and Chief Financial Officer | $403,438 | $2,185,717 |
